Prognostic Value of Malondialdehyde Serum Levels in Severe Sepsis: A Multicenter Study

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Lorente, Leonardo ^a   Martín, María M ^b   Abreu González, Pedro ^c   Domínguez Rodríguez, Alberto ^a   Labarta, Lorenzo ^d   Díaz, César ^e   Solé Violán, Jordi ^f   Ferreres, José ^g   Borreguero León, Juan María ^a   Jiménez, Alejandro ^a   Morera Fumero, Armando ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d HOSPITAL SAN JORGE   (Spain)

^e HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^f HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; INTERLEUKIN 10; LACTIC ACID; MALONALDEHYDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL INFECTION; ADULT; AGED; APACHE; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; HAZARD RATIO; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NEUROLOGIC DISEASE; NONHUMAN; OBSERVATIONAL STUDY; OSTEOMYELITIS; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SKIN INFECTION; SPAIN; SURVIVOR; THROMBOCYTE COUNT; URINARY TRACT INFECTION;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; ROC CURVE; SEPSIS;

EID: 84872360528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053741     Document Type: Article

References (22)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
2. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, et al. (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34: 344-353.
3. Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG, (1991) Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 17: 40-44.
4. Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, et al. (2006) Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 10: R36.
5. Guerreiro MO, Petronilho F, Andrades M, Constantino L, Mina FG, et al. (2010) Plasma superoxide dismutase activity and mortality in septic patients [corrected]. J Trauma 69: E102-106.
6. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, et al. (1996) Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 24: 1179-1183.
7. Moustafa AH, Ali EM, Mohamed TM, Abdou HI, (2009) Oxidative stress and thyroid hormones in patients with liver diseases. Eur J Intern Med 20: 703-708.
8. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530-538.
9. Knaus WA, Draper EA, Wagner DP, Zimmerman JE, (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829.
10. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, et al. (1996) The Sepsis-related Organ Failure Assessment (SOFA) score to describe organ dysfunction/failure. Intensive Care Med 22: 707-710.
11. Kikugawa K, Kojima T, Yamaki S, Kosugi H, (1992) Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid. Anal Biochem 202: 249-255.
12. Harrell FE (2001) Multivariable modelling strategies. In: Harrell FE editors. Regression modelling strategies. With Applications to Linear Models, Logistic Regression, and Survival Analisys. Springer-Verlag. New York (USA). 53-85.
13. Mishra V, Baines M, Wenstone R, Shenkin A, (2005) Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 42: 269-276.
14. Andrades ME, Ritter C, Dal-Pizzol F, (2009) The role of free radicals in sepsis development. Front Biosci (Elite Ed) 1: 277-287.
15. Andrades ME, Morina A, Spasić S, Spasojević I: Bench-to-bedside review, (2011) Sepsis from the redox point of view. Crit Care 15: 230.
16. Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M, (2010) Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Int J Diabetes Dev Ctries 30: 49-51.
17. Xing HY, Ling YL, Meng AH, Zhao XY, Huang XL, (2005) Melatonin improves vascular reactivity of endotoxemia rats. Sheng Li Xue Bao 57: 367-372.
18. Sener G, Toklu H, Kapucu C, Ercan F, Erkanli G, et al. (2005) Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today 35: 52-59.
19. Paskaloǧlu K, Sener G, Kapucu C, Ayanoǧlu-Dülger G, (2004) Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci 74: 1093-1104.
20. Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, et al. (2001) Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 31: 343-349.
21. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, et al. (2001) Effects of melatonin treatment in septic newborns. Pediatr Res 50: 756-760.
22. Sahib AS, Al-Jawad FH, Alkaisy AA, (2010) Effect of antioxidants on the incidence of wound infection in burn patients. Ann Burns Fire Disasters 23: 199-205.